|
|
| (17 intermediate revisions by 5 users not shown) |
| Line 1: |
Line 1: |
| ==Background==
| | #REDIRECT[[Pyoderma gangrenosum]] |
| *1/100,000 people per year in US, primarily 40s-50s yoa
| |
| *Dysfunction of activated neutrophils
| |
| *>50% associated with systemic disease:
| |
| **IBD
| |
| **Polyarthritis, sero-negative and -positive
| |
| **Leukemia
| |
| **Less commonly psoriatic arthritis, OA, RA, spondyloarthopathy, hepatitis, PBC, myelomas, SLE, Sjogren
| |
| | |
| ==Clinical Features==
| |
| | |
| ==Differential Diagnosis==
| |
| {{Travel Skin Conditions DDX}}
| |
| | |
| ==Workup==
| |
| | |
| ==Management==
| |
| | |
| ==Disposition==
| |
| | |
| ==See Also==
| |
| *[[Travel Medicine]]
| |
| | |
| ==External Links==
| |
| | |
| ==Sources==
| |
| <references/>
| |
| | |
| [[Category:ID]]
| |
| [[Category:TropMed]]
| |
